Nonacus has been voted the third fastest growing technology company in the UK in the Deloitte Technology Fast 50

Chris Sale, CEO of Nonacus, and Lee Silcock, CSO, accept their award at the Deloitte 2022 UK Tech Fast 50.

Nonacus announced today that it is ranked third in the Deloitte UK Technology Fast 50 2022.

BIRMINGHAM, WEST MIDLANDS, UK, Nov. 24, 2022 /EINPresswire.com/ — Nonacus today announced that it has ranked third in the Deloitte UK Technology Fast 50 2022, a ranking of the 50 fastest growing technology companies in the United Kingdom . The rankings are based on percentage sales growth over the last four years.

Chris Sale, CEO of Nonacus, said: “Nonacus’ mission is to enable state-of-the-art genetic cancer testing at an affordable cost, so more cancer patients can benefit from the right therapy choices and through liquid biopsy and MRD monitoring to determine treatment success and relapses to recognize earlier. I am pleased to see our genetic testing and products being used by a growing number of healthcare systems and laboratories around the world.”

Duncan Down, Lead Partner of the Deloitte UK Technology Fast 50 programme, said: “The exceptional growth of this year’s Fast 50 is a sign of the continued strength and resilience of the UK technology industry, which continues to thrive despite significant headwinds.

“The Deloitte 2022 Fast 50 awards showcase the talent and innovation in the UK technology industry today. The Deloitte UK Technology Fast 50 awards give companies the opportunity to be recognized and rewarded for their contributions to the UK technology sector and achievements over the past four years.

“The 50 fastest growing UK technology companies, according to the Deloitte ranking, had total annual sales of around £992m in 2021/22 and employed more than 16,300 people. The Deloitte UK Technology Fast 50 recorded a compound three-year growth rate of 4,568 percent.”

About Nonacus
Nonacus is focused on providing innovative technologies to the genomic healthcare sector by using cell-free circulating DNA as a non-invasive diagnostic tool.

Nonacus was developed by a team of highly motivated scientists and industry professionals with experience in translating research into routine diagnostic tools for the benefit of patients. Nonacus provides a complete liquid biopsy analysis workflow with the goal of enabling better cancer treatment through earlier diagnosis, treatment stratification and monitoring.

About the Deloitte UK Technology Fast 50
The Deloitte UK Technology Fast 50 is one of the UK’s leading technology awards programmes. Now in its 25th year, it ranks the 50 fastest growing technology companies in the country based on revenue growth over the past four years. The UK Fast 50 Awards is all about growth driven by leading intellectual property and celebrates innovation and entrepreneurship. Previous winners have come from across the UK, are both large and small and have included some of the most dynamic players across all technology sectors, from IoT to BioTech, Digital Media Technology to Life Sciences, FinTech to Software and Clean Energy to Telecoms.

Paula Mikel
Nonacus Limited
+44 7484 620547
email us here



Source

Leave a Reply

Your email address will not be published. Required fields are marked *